Buradasınız

Periton Diyalizi Hastalarında Sen Virüsü Varyantı Olan Senv-D ve Senv-H’nin Prevalansı

Prevalence of Senv-D and Senv-H Variants of Sen Virus in Peritoneal Dialysis Patients

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
OBJECTIVE: Patients on peritoneal dialysis are at high risk of blood-borne infections due to frequent blood transfusions. We aimed to determine and compare the prevalence of SENVD and SENV-H variants of the SEN virus (SENV) in these patients. MATERIAL and METHOD: A total of 143 subjects, 43 on peritoneal dialysis and 100 healthy controls, were included in this point-prevalence study. SENV-D and SENV-H DNAs were detected with the polymerase chain reaction. RESULTS: The prevalence of SENV-D was 23.2% in peritoneal dialysis patients. The prevalence of SENV-H being 20.9% in peritoneal dialysis patients was found to be higher than that of SENV-D. SENV-H prevalence was not significantly higher in our patient population compared with healthy subjects (16.0%). On the other hand, SENV-D was significantly more prevalent in all patient groups compared to healthy control subjects (5.0%). There was no association between SENV and HCV. CONCLUSIONS: SEN virus infection, particularly SENV-D variant, has high prevalence in patients on peritoneal dialysis in Turkey. Care should be taken for SENV hepatitis and transmission of virus among these patients.
Abstract (Original Language): 
AMAÇ: Kan transfüzyonları sebebiyle kan ile taşınan enfeksiyonlar periton diyalizi hastalarında daha sık görülür. Bu çalışmanın amacı, bu hastalarda SEN virüslerinin (SENV) SENV-D ve SENV-H tiplerinin sıklığını tespit etmek ve birbiriyle karşılaştırmaktır. GEREÇ ve YÖNTEM: 100 sağlıklı kontrol, 43 periton diyalizi hastası olmak üzere 143 hasta bu çalışmaya dahil edildi. SENV-D ve SENV-H DNA polymerase chain reaction yöntemi ile çalışıldı. BULGULAR: Periton diyalizi hastalarında; SENV-D sıklığı %23.2, SENV-H %20.9 bulundu. SENV-H sıklığı sağlıklı grup (%16.0) ile karşılaştırıldığında anlamlı olarak yüksek değildi. Diğer yandan SENV-D sağlıklı grup (%5.0) ile karşılaştırıldığında anlamlı olarak yüksek bulundu. SENV ile HCV arasında birliktelik tespit edilmedi. SONUÇ: SEN virüs enfeksiyonu ve özellikle SENV-D tipi Türkiye’deki periton diyalizi hastalarında sağlıklı gruba göre daha yüksek sıklıkla görülmektedir. SEN-V ve HCV arasında birliktelik tespit edilmemiştir.
107-111

REFERENCES

References: 

1. Primi D, Fiordalisi G, Mantero J: Identification of senv
genotypes. Int publ no wo0028039. May 18, 2000
2. Tanaka Y, Primi D, Wang RY, Umemura T, Yeo AE,
Mizokami M, Alter HJ, Shih JW: Genomic and molecular
evolutionary analysis of a newly identified infectious agent
(sen virus) and its relationship to the tt virus family. J Infect
Dis 2001; 183: 359-367
3. Umemura T, Yeo AE, Sottini A, Moratto D, Tanaka Y,
Wang RY, Shih JW, Donahue P, Primi D, Alter HJ: Sen
virus infection and its relationship to transfusion-associated
hepatitis. Hepatology 2001; 33: 1303-1311
4. Kao JH, Chen W, Chen PJ, Lai MY, Chen DS: Prevalence
and implication of a newly identified infectious agent (sen
virus) in taiwan. J Infect Dis 2002; 185: 389-392
5. Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P,
Sterneck M, Fischer L, Feucht HH: Prevalence of senv-h
viraemia among healthy subjects and individuals at risk for
parenterally transmitted diseases in Germany. J Viral Hepat
2002; 9: 455-459
6. Kobayashi N, Tanaka E, Umemura T, Matsumoto A, Iijima
T, Higuchi M, Hora K, Kiyosawa K: Clinical significance
of sen virus infection in patients on maintenance
haemodialysis. Nephrol Dial Transplant 2003; 18: 348-352
7. Umemura T, Tanaka E, Ostapowicz G, Brown KE,
Heringlake S, Tassopoulos NC, Wang RY, Yeo AE, Shih
JW, Orii K, Young NS, Hatzakis A, Manns MP, Lee WM,
Kiyosawa K, Alter HJ: Investigation of sen virus infection
in patients with cryptogenic acute liver failure, hepatitisassociated
aplastic anemia, or acute and chronic non-a-e
hepatitis. J Infect Dis 2003; 188: 1545-1552
8. Kao JH, Chen W, Chen PJ, Lai MY, Chen DS: Sen virus
infection in patients with chronic hepatitis C: Preferential
coinfection with hepatitis C genotype 2a and no effect on
response to therapy with interferon plus ribavirin. J Infect
Dis 2003; 187: 307-310
9. Rigas B, Hasan I, Rehman R, Donahue P, Wittkowski KM,
Lebovics E: Effect on treatment outcome of coinfection
with sen viruses in patients with hepatitis C. Lancet 2001;
358: 1961-1962
10. Narayanan Menon KV: Non-a to e hepatitis. Curr Opin
Infect Dis 2002; 15: 529-534
11. Pirovano S, Gregorini G, Malacarne F, Marini M, Albertini
A, Imberti L: High prevalence of sen virus infection in
patients on maintenance hemodialysis: Frequent mixed
infections with different variants and evidence for
nosocomial transmission of the virus. Intervirology 2005;
48: 216-222
12. Schréter I, Kristian P, Jarcuska P, Porubcin S, Siegfried L,
Birosová E, Rajnic A, Gocalová A: Detection of sen virus in
the general population and different risk groups in Slovakia.
Folia Microbiol (Praha) 2006; 51: 223-228
13. Dai CY, Chuang WL, Chang WY, Chen SC, Sung MH,
Hsieh MY, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Yu
ML: Sen virus infection among patients on maintenance
hemodialysis in Southern Taiwan. J Infect 2005; 51: 110-
115
14. Schroter M, Laufs R, Zollner B, Knodler B, Schafer P,
Feucht HH: A novel DNA virus (sen) among patients
on maintenance hemodialysis: Prevalence and clinical
importance. J Clin Virol 2003; 27: 69-73
15. Borawski J, Kovalchuk O, Chlebińska I, Naumnik B,
Rydzewska-Rosołowska A, Chyczewski L, Myśliwiec M:
Sen virus infection in maintenance hemodialysis patients.
Wiad Lek 2006; 59: 751-756
Öğütmen M et al: Prevalence of Senv-D and Senv-H Variants
of Sen Virus in Peritoneal Dialysis Patients
Cilt/Vol. 18, No, 3, 2009 Sayfa/Page 107-111
110
Türk Nefroloji Diyaliz ve Transplantasyon Dergisi
Turkish Nephrology, Dialysis and Transplantation Journal
111
16. Serin MS, Tezcan S, Delialioglu N, Tiftik N, Aslan G,
Emekdas G: Investigation of sen virus genotypes d and h
among blood donors in mersin university medical school
hospital. Mikrobiyol Bul 2006; 40: 39-45
17. Barril G, López-Alcorocho JM, Bajo A, Ortiz-Movilla N,
Sánchez-Tomero JA, Bartolomé J, Selgas R, Carreño V:
Prevalence of tt virus in serum and peripheral mononuclear
cells from a capd population. Perit Dial Int 2000; 20: 65-
68
18. Ozener IC, Ture F, Koc M, Avsar E: Prevalence of tt virus in
a capd population. Nephron 2002; 91: 341-343
19. Di Bisceglie AM: Sen and sensibility: Interactions between
newly discovered and other hepatitis viruses? Lancet 2001;
358: 1925-1926
20. Umemura T, Alter HJ, Tanaka E, Yeo AE, Shih JW, Orii
K, Matsumoto A, Yoshizawa K, Kiyosawa K: Association
between sen virus infection and hepatitis C in Japan. J Infect
Dis 2001; 184: 1246-1251

Thank you for copying data from http://www.arastirmax.com